Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
111.60
-0.40 (-0.36%)
At close: May 26, 2025
-29.72%
Market Cap 25.78B
Revenue (ttm) 11.58B
Net Income (ttm) 570.05M
Shares Out 231.00M
EPS (ttm) 2.47
PE Ratio 45.22
Forward PE n/a
Dividend 2.00 (1.79%)
Ex-Dividend Date Oct 28, 2024
Volume 39,369
Average Volume 78,509
Open 113.50
Previous Close 112.00
Day's Range 110.30 - 113.90
52-Week Range 92.40 - 169.00
Beta -0.35
RSI 52.08
Earnings Date Apr 30, 2025

About Beacon Pharmaceuticals

Beacon Pharmaceuticals PLC engages in the producing and promoting of pharmaceuticals finished formulations, lifesaving intravenous fluids, active pharmaceutical ingredients, bio-tech products, and genetic engineering products in Bangladesh and internationally. The company offers general, oncology, biotech, and chronic care products. It also provides products in various therapeutic categories that include oncology, hematology, hepatology, nephrology, antibiotics, analgesics, anti-diabetics, respiratory, cardiovascular, dermatology, gastrointesti... [Read more]

Industry Pharmaceutical Preparations
Founded 2001
Employees 4,162
Stock Exchange Dhaka Stock Exchange
Ticker Symbol BEACONPHAR
Full Company Profile

Financial Performance

In 2024, Beacon Pharmaceuticals's revenue was 10.70 billion, an increase of 25.76% compared to the previous year's 8.51 billion. Earnings were 521.01 million, an increase of 2.19%.

Financial Statements

News

There is no news available yet.